Interestingly, the sensitivity to SREBP depletion was not restricted to RPE cells but could also be demonstrated in a panel of breast cancer cell lines in which the PI3-kinase pathway is activated by loss of function of PTEN or activating mutations in PIK3CA or KRAS. The gene discussed is PIK3CA; the disease is breast carcinoma.